As an expert in oncology and cardiology, Daiichi Sankyo is tackling the most common causes of death in Germany and Europe: strokes, heart attacks and cancer. Formed by a merger, the Japanese pharmaceutical company develops innovative drugs and therapeutic approaches. J-BIG spoke to Dr Martina Witzel, Head of Oncology Germany, and Benoit Creveau, General Manager for Daiichi … [Read more...] about Daiichi Sankyo“A company that is only interested in profit will not be successful”
Footer
Interview Archive
Leadership Dojo “We’re creating a safe space for leaders to step beyond titles to explore deeper connection and cross‑cultural leadership mastery.”
Leadership Advisory Consultant Yoshiko Ogawa from Egon Zehnder and Bjoern Eichstaedt, Founder and Chief Editor of J-BIG and Co-owner and Managing Partner of communications agency Storymaker, are launching “Leadership Dojo” …
NUKEM “In Germany, the nuclear debate is conducted ideologically. The Japanese take a more pragmatic view.”
The nuclear company NUKEM looks back on 65 years of history in Germany – from fuel element production in the 1960s to its current specialisation in nuclear power plant decommissioning …
SBI Ventures Europe “With our investments we bring new technologies and innovative ideas across markets.”
SBI Holdings, born from SoftBank’s investment division, has evolved from an online financial services pioneer in Japan to a global financial conglomerate with over 700 companies and 19,000 employees worldwide. …